Quipt Home Medical Corp. (NASDAQ:QIPT) Receives $6.25 Average PT from Brokerages

Shares of Quipt Home Medical Corp. (NASDAQ:QIPT) have received an average rating of “Buy” from the six research firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a buy rating and two have issued a strong buy rating on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $6.25.

A number of equities analysts have commented on QIPT shares. Canaccord Genuity Group decreased their price target on Quipt Home Medical from $8.00 to $6.00 and set a “buy” rating on the stock in a research note on Friday, August 16th. Benchmark decreased their target price on shares of Quipt Home Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research note on Wednesday, August 21st.

Quipt Home Medical Stock Up 2.9 %

QIPT opened at $2.47 on Wednesday. Quipt Home Medical has a 12 month low of $2.34 and a 12 month high of $5.29. The company has a current ratio of 1.11, a quick ratio of 0.77 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $2.72 and its 200-day moving average price is $3.04. The company has a market cap of $106.43 million, a P/E ratio of -22.45 and a beta of 0.62.

Institutional Investors Weigh In On Quipt Home Medical

Large investors have recently made changes to their positions in the business. ProShare Advisors LLC purchased a new position in shares of Quipt Home Medical during the second quarter valued at about $35,000. SG Americas Securities LLC purchased a new position in shares of Quipt Home Medical during the 3rd quarter worth approximately $44,000. Atom Investors LP bought a new position in shares of Quipt Home Medical in the 3rd quarter worth approximately $51,000. XTX Topco Ltd purchased a new position in shares of Quipt Home Medical in the 3rd quarter valued at approximately $54,000. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Quipt Home Medical by 25.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,829 shares of the company’s stock valued at $57,000 after purchasing an additional 2,640 shares in the last quarter. 42.85% of the stock is currently owned by institutional investors.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.